Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIHUAN PHARM

0.650
+0.0203.17%
Volume:38.02M
Turnover:24.66M
Market Cap:6.02B
PE:-26.19
High:0.660
Open:0.630
Low:0.630
Close:0.630
Loading ...

Sihuan Pharma - Repurchased 10 Mln Shares of Co at Average Price of HK$0.5723 per Share

THOMSON REUTERS
·
11 Feb

BUZZ-China's Sihuan Pharmaceutical falls on wider annual loss outlook

Reuters
·
04 Feb

BRIEF-Sihuan Pharma Sees FY Revenue Of Not Less Than RMB1,800 Mln & Loss Of Not More Than RMB600 Mln

Reuters
·
03 Feb

Sihuan Pharmaceutical Forecasts Maximum Loss of 600 Million Yuan for 2024

MT Newswires Live
·
03 Feb

Sihuan Pharma Sees Revenue of Not Less Than RMB1,800 Mln and Loss of Not More Than RMB600 Mln for Year

THOMSON REUTERS
·
03 Feb

Sihuan Pharmaceutical Holdings Group (HKG:460 shareholders incur further losses as stock declines 7.0% this week, taking three-year losses to 40%

Simply Wall St.
·
20 Dec 2024

BRIEF-Sihuan Pharma Says Proposes To Spin Off Xuanzhu Biopharm

Reuters
·
25 Nov 2024

Sihuan Pharma - Submitted Listing Application Form to Apply for Listing of Spinco H Shares

THOMSON REUTERS
·
25 Nov 2024

Sihuan Pharma - Proposes to Spin off Xuanzhu Biopharm and Separately List Its H Shares on Main Board of Stock Exchange

THOMSON REUTERS
·
25 Nov 2024

BRIEF-Sihuan Pharma Says Unit Enters Exclusive Authorization Cooperation For Semaglutide Injection

Reuters
·
21 Nov 2024

Sihuan Pharmaceutical Units Sign Cooperation Deal for Weight Loss Drug Distribution

MT Newswires Live
·
21 Nov 2024

Sihuan Pharma - Unit Entered Exclusive Authorization Cooperation With Meiyan Space for Semaglutide Injection

THOMSON REUTERS
·
21 Nov 2024

Private companies are Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) biggest owners and were hit after market cap dropped HK$559m

Simply Wall St.
·
16 Nov 2024

BRIEF-Sihuan Pharma Announces Proposed Spin-Off Of Xuanzhu Biopharm

Reuters
·
13 Nov 2024

Sihuan Pharma - Proposed Spin-off of Xuanzhu Biopharm and Listing on Main Board of Stock Exchange

THOMSON REUTERS
·
12 Nov 2024

Sihuan Pharma - Unit to Further Acquire 3.6177% Stake in Xuanzhu Biopharmaceutical for RMB308 Mln

THOMSON REUTERS
·
12 Nov 2024